Covid-19 vaccines—immunity, variants, boosters
DH Barouch - New England Journal of Medicine, 2022 - Mass Medical Soc
Covid-19 Vaccines — Immunity, Variants, Boosters | New England Journal of Medicine Skip to
main content The New England Journal of Medicine homepage Advanced Search SEARCH …
main content The New England Journal of Medicine homepage Advanced Search SEARCH …
New‐onset autoimmune phenomena post‐COVID‐19 vaccination
Y Chen, Z Xu, P Wang, XM Li, ZW Shuai, DQ Ye… - …, 2022 - Wiley Online Library
Abstract Coronavirus disease 2019 (COVID‐19) pandemic caused by severe acute
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has led to an unprecedented setback for …
respiratory syndrome coronavirus 2 (SARS‐CoV‐2) has led to an unprecedented setback for …
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis
Vaccination is a major tool for mitigating the coronavirus disease 2019 (COVID-19)
pandemic, and mRNA vaccines are central to the ongoing vaccination campaign that is …
pandemic, and mRNA vaccines are central to the ongoing vaccination campaign that is …
The state of complement in COVID-19
Hyperactivation of the complement and coagulation systems is recognized as part of the
clinical syndrome of COVID-19. Here we review systemic complement activation and local …
clinical syndrome of COVID-19. Here we review systemic complement activation and local …
Final analysis of efficacy and safety of single-dose Ad26. COV2. S
J Sadoff, G Gray, A Vandebosch… - … England Journal of …, 2022 - Mass Medical Soc
Abstract Background The Ad26. COV2. S vaccine was highly effective against severe–
critical coronavirus disease 2019 (Covid-19), hospitalization, and death in the primary phase …
critical coronavirus disease 2019 (Covid-19), hospitalization, and death in the primary phase …
Covid‐19 vaccines and variants of concern: a review
I Hadj Hassine - Reviews in medical virology, 2022 - Wiley Online Library
Since the outbreak of coronavirus disease 2019 (Covid‐19) in December 2019, caused by
the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the number of …
the severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the number of …
Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review
M Sharifian-Dorche, M Bahmanyar… - Journal of the …, 2021 - Elsevier
Introduction The common reported adverse effects of COVID-19 vaccination consist of the
injection site's local reaction followed by several non-specific flu-like symptoms. However …
injection site's local reaction followed by several non-specific flu-like symptoms. However …
The use of viral vectors in vaccine development
Vaccines represent the single most cost-efficient and equitable way to combat and eradicate
infectious diseases. While traditional licensed vaccines consist of either …
infectious diseases. While traditional licensed vaccines consist of either …
Vaccine-induced immune thrombotic thrombocytopenia
In response to the COVID-19 pandemic, vaccines for SARS-CoV-2 were developed, tested,
and introduced at a remarkable speed. Although the vaccine introduction had a major …
and introduced at a remarkable speed. Although the vaccine introduction had a major …
Ocular adverse events after COVID-19 vaccination
XL Ng, BK Betzler, I Testi, SL Ho, M Tien… - Ocular immunology …, 2021 - Taylor & Francis
Purpose The COVID-19 pandemic has galvanized the development of new vaccines at an
unprecedented pace. Since the widespread implementation of vaccination campaigns …
unprecedented pace. Since the widespread implementation of vaccination campaigns …